Haemorrhage intracranial

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
B Haematology (ATC B) 1
Mechanism of action (INN-stem analysis)
Factor Xa inhibitor (DOAC) 1 substance
Phase IV: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase IV

1 trial
  • Hamilton Health Sciences Corporation Academic
    EDOXABAN
    2024-518508-31-00 10 countries n=380
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Hamilton Health Sciences Corporation Academic 1 Phase IV 0
← All indication landscapes